logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Janssen Pharmaceuticals, Inc. drugs

    FiltersReset Filters
    14 results

    • concerta

      (Methylphenidate hydrochloride)
      Janssen Pharmaceuticals, Inc.
      Usage: CONCERTA is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children aged 6 and older, adolescents, and adults up to 65 years old.

    • elmiron

      (PENTOSAN POLYSULFATE SODIUM)
      Janssen Pharmaceuticals, Inc.
      Usage: ELMIRON® (pentosan polysulfate sodium) is indicated for relieving bladder pain or discomfort associated with interstitial cystitis.

    • haldol decanoate - haloperidol decanoate injection

      (Haloperidol Decanoate)
      Janssen Pharmaceuticals, Inc.

    • invega - paliperidone tablet, extended release

      (Paliperidone)
      Janssen Pharmaceuticals, Inc.

    • invega sustenna

      (paliperidone palmitate)
      Janssen Pharmaceuticals, Inc.
      Usage: INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of schizophrenia and schizoaffective disorder in adults, both as monotherapy and as an adjunct to mood stabilizers or antidepressants.

    • invokamet

      (canagliflozin and metformin hydrochloride)
      Janssen Pharmaceuticals, Inc.
      Usage: INVOKAMET and INVOKAMET XR are indicated as adjuncts to diet and exercise for improving glycemic control in adults and pediatric patients aged 10 and older with type 2 diabetes mellitus. Canagliflozin component reduces risks of major cardiovascular events and kidney disease in specific patient populations.

    • invokana

      (canagliflozin)
      Janssen Pharmaceuticals, Inc.
      Usage: INVOKANA (canagliflozin) is indicated as an adjunct to diet and exercise for improving glycemic control in adults and pediatric patients with type 2 diabetes. It reduces risks of major cardiovascular events and end-stage kidney disease in adults with type 2 diabetes and specific health complications. Usage in type 1 diabetes or severe renal impairment is not recommended.

    • ponvory

      (Ponesimod)
      Janssen Pharmaceuticals, Inc.
      Usage: PONVORY is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

    • risperdal

      (risperidone)
      Janssen Pharmaceuticals, Inc.
      Usage: RISPERDAL (risperidone) is indicated for the treatment of schizophrenia, acute manic or mixed episodes of Bipolar I Disorder (as monotherapy or adjunctive therapy), and irritability associated with autistic disorder in children and adolescents. Efficacy is supported by multiple clinical trials in various age groups.

    • risperdal consta - risperidone

      (Risperidone)
      Janssen Pharmaceuticals, Inc.